Should the acknowledged higher risk of a second primary breast cancer in women who survive their primary unilateral lesion mandate prophylactic removal of the contralateral breast? Or should this approach be reserved for those in extremely high-risk groups, with reliance on rigorous and meticulous follow-up for the others? Dr. Lewison details the evidence on both sides of these difficult questions.